BackgroundCheck.run
Search For

Daniel S Lundell, 453705 Hickory Branch Trl, Suwanee, GA 30024

Known as:
Daniel S Loundell
Related to:
Mary Jane Lundell 67 Rachel Lundell 43

Daniel Lundell Phones & Addresses

3705 Hickory Branch Trl, Suwanee, GA 30024    678-5463546   

Berkeley Heights, NJ   

1 Paris Ave, Edison, NJ 08820    732-3210838   

1030 Grove Ave, Edison, NJ 08820    908-6681880   

1030 Grove Ave #34A, Edison, NJ 08820    732-6681880   

3705 Hickory Branch Trl, Suwanee, GA 30024    732-6681880   

Get Report
Control this profile

Mentions for Daniel S Lundell

Daniel Lundell resumes & CV records

Resumes

Daniel Lundell Photo 14

Clinical Field Engineer

Location:
Atlanta, GA
Industry:
Medical Devices
Work:
Trinity Biotech Aug 2005 - Aug 2012
Field Service Dispatch Support Trinity Biotech Aug 2005 - Aug 2012
Clinical Field Engineer
Education:
Middlesex County College 1997 - 2001
Associates, Marketing, Management, Business Management, Business
Skills:
Hardware Diagnostics, Technical Support, Inventory Management, Iso 13485, Operations Management, Salesforce.com, Medical Devices, Accounts Receivable, Materials Management, Sales Operations, Troubleshooting, Customer Service, Crm, Process Improvement, Training, Team Building, Capital Equipment, Capa, Microsoft Word, Windows
Daniel Lundell Photo 15

Daniel Lundell

Publications & IP owners

Us Patents

3,4-Di-Substituted Cyclobutene-1,2-Diones As Cxc-Chemokine Receptor Ligands

US Patent:
7132445, Nov 7, 2006
Filed:
Jul 30, 2003
Appl. No.:
10/630258
Inventors:
Arthur G. Taveras - Denville NJ, US
Cynthia J. Aki - Livingston NJ, US
Richard W. Bond - Union NJ, US
Jianping Chao - Summit NJ, US
Michael Dwyer - Scotch Plains NJ, US
Johan A. Ferreira - Bethlehem PA, US
Jianhua Chao - Pompton Lakes NJ, US
Younong Yu - Scotch Plains NJ, US
John J. Baldwin - Gwynedd Valley PA, US
Bernd Kaiser - Wallingford CT, US
Ge Li - Shanghai, CN
J. Robert Merritt - Ewing NJ, US
Purakkattle J. Biju - Scotch Plains NJ, US
Laura L. Rokosz - Union NJ, US
James P. Jakway - Bridgewater NJ, US
Gaifa Lai - Edison NJ, US
Minglang Wu - Monmouth Junction NJ, US
Evan A. Hecker - Austin TX, US
Daniel Lundell - Flemington NJ, US
Jay S. Fine - Bloomfield NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
Pharmacopeia Drug Discovery, Inc. - Cranbury NJ
International Classification:
A61K 31/341
A61K 31/343
A61K 31/381
C07D 333/10
C07D 33/72
US Classification:
514438, 514443, 514469, 514471, 549 58, 549 77, 549469, 549494
Abstract:
There are disclosed compounds of the formula.

Treatment Of Chemokine Mediated Diseases

US Patent:
2004005, Mar 18, 2004
Filed:
Mar 17, 2003
Appl. No.:
10/390078
Inventors:
Arthur Taveras - Denville NJ, US
Motasim Billah - Edison NJ, US
Daniel Lundell - Flemington NJ, US
William Kreutner - West Paterson NJ, US
James Jakway - Bridgewater NJ, US
Jay Fine - Bloomfield NJ, US
Loretta Bober - Linden NJ, US
Jianhua Chao - Pompton Lakes NJ, US
Purakkattle Biju - Scotch Plains NJ, US
Younong Yu - Scotch Plains NJ, US
Assignee:
Schering Corporation
International Classification:
A61K031/44
A61K031/426
A61K031/421
A61K031/4172
A61K031/34
US Classification:
514/277000, 514/365000, 514/374000, 514/400000, 514/357000, 514/471000
Abstract:
Methods of treating chemokine-mediated diseases are disclosed. The methods comprise the administration of CXC-Chemokine receptor antagonists of the formula or pharmaceutically acceptable salts or solvates thereof, in combination with other classes of pharmaceutical compounds. The chemokine-mediated diseases include acute and chronic inflammatory disorders, psoriasis, cystic fibrosis, asthma and cancer. Also disclosed are novel compounds of formula (I).

Cxcr1 And Cxcr2 Chemokine Antagonists

US Patent:
2006001, Jan 19, 2006
Filed:
May 11, 2005
Appl. No.:
11/126977
Inventors:
Jianhua Chao - Pompton Lakes NJ, US
Arthur Taveras - Southborough MA, US
Cynthia Aki - Livingston NJ, US
Daniel Lundell - Flemington NJ, US
Jay Fine - Bloomfield NJ, US
Tony Priestley - Bridgewater NJ, US
Angelo Reggiani - Milan, IT
International Classification:
A61K 31/454
US Classification:
514326000
Abstract:
The present invention is directed to a compound having the general structure of formula (1): useful for the treatment, prevention or amelioration of a CXCR1 or CXCR2 chemokine-mediated disease.

Thiadiazoles As Cxc- And Cc- Chemokine Receptor Ligands

US Patent:
2006022, Oct 5, 2006
Filed:
Dec 16, 2004
Appl. No.:
11/013753
Inventors:
Purakkattle Biju - Scotch Plains NJ, US
Arthur Taveras - Southborough MA, US
J. Merritt - Ewing NJ, US
John Baldwin - Gwynedd Valley PA, US
Younong Yu - East Brunswick NJ, US
Junying Zheng - Bridgewater NJ, US
Jianhua Chao - Pompton Lakes NJ, US
Cynthia Aki - Livingston NJ, US
Jay Fine - Bloomfield NJ, US
Daniel Lundell - Flemington NJ, US
Tony Priestley - Bridgewater NJ, US
Angelo Reggiani - Milan, IT
International Classification:
A61K 31/4439
A61K 31/433
C07D 417/02
US Classification:
514341000, 514363000, 546268700, 548134000
Abstract:
Disclosed are novel compounds of the formula: and the pharmaceutically acceptable salts and solvates thereof. Examples of groups comprising Substituent A include heteroaryl, aryl, heterocycloalkyl, cycloalkyl, aryl, alkynyl, alkenyl, aminoalkyl, alkyl or amino. Examples of groups comprising Substituent B include aryl and heteroaryl. Also disclosed is a method of treating a chemokine mediated diseases, such as, cancer, angiogenisis, angiogenic ocular diseases, pulmonary diseases, multiple sclerosis, rheumatoid arthritis, osteoarthritis, stroke and ischemia reperfusion injury, pain (e.g., acute pain, acute and chronic inflammatory pain, and neuropathic pain) using a compound of formula IA.

3,4-Di-Substituted Cyclobutene-1,2-Diones As Cxc-Chemokine Receptor Ligands

US Patent:
2007002, Jan 25, 2007
Filed:
Aug 8, 2006
Appl. No.:
11/500739
Inventors:
Arthur Taveras - Denville NJ, US
Cynthia Aki - Livingston NJ, US
Richard Bond - Union NJ, US
Jianping Chao - Summit NJ, US
Michael Dwyer - Scotch Plains NJ, US
Johan Ferreira - Bensalem PA, US
Jianhua Chao - Pompton Lakes NJ, US
Younong Yu - Piscataway NJ, US
John Baldwin - Gwynedd Valley PA, US
Bernd Kaiser - Walingford CT, US
Ge Li - Shanghai, CN
J. Merritt - Ewing NJ, US
Purakkattle Biju - Scotch Plains NJ, US
Kingsley Nelson - Mebane NC, US
Laura Rokosz - Union NJ, US
Gaifa Lai - Edison NJ, US
James Jakway - Bridgewater NJ, US
Minglang Wu - Monmouth Junction NJ, US
Evan Hecker - Austin TX, US
Daniel Lundell - Flemington NJ, US
Jay Fine - Bloomfield NJ, US
International Classification:
A61K 31/4709
A61K 31/4436
A61K 31/427
A61K 31/422
A61K 31/4178
A61K 31/381
C07D 409/02
C07D 413/02
C07D 417/02
US Classification:
514444000, 514314000, 514342000, 514406000, 514365000, 514374000, 514397000, 549059000, 549060000, 548190000, 548235000, 548315100, 546159000, 546281400
Abstract:
There are disclosed compounds of the formula or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.

Cxcr1 And Cxcr2 Chemokine Antagonists

US Patent:
2007024, Oct 25, 2007
Filed:
Jul 10, 2007
Appl. No.:
11/775567
Inventors:
Jianhua Chao - Pompton Lakes NJ, US
Arthur Taveras - Southborough MA, US
Cynthia Aki - Livingston NJ, US
Daniel Lundell - Flemington NJ, US
Jay Fine - Bloomfield NJ, US
Tony Priestley - Bridgewater NJ, US
Angelo Reggiani - Milan, IT
International Classification:
A61K 31/381
A61K 31/4015
A61K 31/4025
A61K 31/4152
A61K 31/425
A61K 31/4436
A61K 31/497
A61K 31/5355
A61K 31/675
A61K 31/70
A61K 31/727
A61K 39/395
C07D 207/36
C07D 241/04
C07D 275/03
C07D 333/36
C07D 409/12
C07D 413/12
US Classification:
424130100, 514231500, 514252130, 514336000, 514369000, 514407000, 514422000, 514423000, 514043000, 514444000, 514445000, 514447000, 514056000, 514090000, 544145000, 544374000, 546280400, 548213000, 548366700, 548527000, 548537000, 549063000, 549068000
Abstract:
The present invention is directed to a compound having the general structure of formula (1): useful for the treatment, prevention or amelioration of a CXCR1 or CXCR2 chemokine-mediated disease.

Thiadiazoles As Cxc- And Cc- Chemokine Receptor Ligands

US Patent:
2008009, Apr 17, 2008
Filed:
Sep 26, 2007
Appl. No.:
11/861870
Inventors:
Purakkattle Biju - Piscataway NJ, US
Arthur Taveras - Southborough MA, US
J. Merritt - Ewing NJ, US
John Baldwin - Gwynedd Valley PA, US
Younong Yu - East Brunswick NJ, US
Junying Zheng - Bridgewater NJ, US
Jianhua Chao - Pompton Lakes NJ, US
Cynthia Aki - Livingston NJ, US
Jay Fine - Bloomfield NJ, US
Daniel Lundell - Flemington NJ, US
Tony Priestley - Bridgewater NJ, US
Angelo Reggiani - Milan, IT
International Classification:
A61K 31/433
A61K 31/496
A61K 31/5377
A61P 19/00
A61P 25/00
A61P 3/00
A61P 37/00
A61P 9/00
C07D 285/10
C07D 417/10
C07D 417/14
US Classification:
514236200, 514253100, 514362000, 544134000, 544364000, 548135000
Abstract:
Disclosed are novel compounds of the formula: and the pharmaceutically acceptable salts and solvates thereof. Examples of groups comprising Substituent A include heteroaryl, aryl, heterocycloalkyl, cycloalkyl, aryl, alkynyl, alkenyl, aminoalkyl, alkyl or amino. Examples of groups comprising Substituent B include aryl and heteroaryl. Also disclosed is a method of treating a chemokine mediated diseases, such as, cancer, angiogenisis, angiogenic ocular diseases, pulmonary diseases, multiple sclerosis, rheumatoid arthritis, osteoarthritis, stroke and ischemia reperfusion injury, pain (e.g., acute pain, acute and chronic inflammatory pain, and neuropathic pain) using a compound of formula IA.

3,4-Di-Substituted Cyclobutene-1,2-Diones As Cxc-Chemokine Receptor Ligands

US Patent:
2011021, Sep 1, 2011
Filed:
May 6, 2011
Appl. No.:
13/102554
Inventors:
Arthur G. Taveras - Denville NJ, US
Cynthia J. Aki - Livingston NJ, US
Richard W. Bond - Union NJ, US
Jianping Chao - Summit NJ, US
Michael Dwyer - Scotch Plains NJ, US
Johan A. Ferreira - Bensalem PA, US
Jianhua Chao - Pompton Lakes NJ, US
Younong Yu - Piscataway NJ, US
John J. Baldwin - Gwynedd Valley PA, US
Bernd Kaiser - Wallingford CT, US
Ge Li - Shanghai, CN
J. Robert Merritt - Ewing NJ, US
Purakkattle J. Biju - Scotch Plains NJ, US
Laura L. Rokosz - Union NJ, US
Gaifa Lai - Edison NJ, US
James P. Jakway - Bridgewater NJ, US
Minglang Wu - Monmouth Junction NJ, US
Evan A. Hecker - Austin TX, US
Daniel Lundell - Flemington NJ, US
Jay S. Fine - Bloomfield NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
Pharmacopeia Drug Discovery - Cranbury NJ
International Classification:
A61K 31/341
A61P 11/00
US Classification:
514471
Abstract:
There are disclosed compounds of the formulaor a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.

Possible Relatives

David P Lundell  Donald P Lundell  Eric P Lundell  Erik C Lundell  Erin E Lundell  Frank C Lundell  Heil C Lundell  Daniel G Last  Daniel J Johnson  Daniel W Stamps 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.